NSE filing, NSE: MEDISTEP. Summary written from the filing by ALFA Finder's alert engine.
Medistep Healthcare Ltd: key numbers
- Share price
- ₹18.75
- Market cap
- ₹26.64 Cr
- Revenue (annual)
- ₹70.83 Cr
- Net profit (annual)
- ₹5.98 Cr
- P/E (TTM)
- 4.5×Sector 46.1×
- Promoter holding
- 68.96%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medistep Healthcare Ltd
All →Medistep Healthcare Other Announcement
Medistep Healthcare Limited has submitted the compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Medistep Healthcare Annual General Meeting
Medistep Healthcare Limited held its 3rd Annual General Meeting on September 17, 2026. Shareholders transacted on financial statements, director re-appointment, and investment thresholds.
Medistep Healthcare Other Announcement
Medistep Healthcare Limited has appointed M/s. Kapil Kumar Agarwal & Associates as Internal Auditor and M/s. Vaibhav Sharma & Associates as Secretarial Auditor.
Medistep Healthcare Annual General Meeting
Medistep Healthcare Limited has issued a notice for its 3rd Annual General Meeting (AGM) to be held on September 17, 2026. The filing includes the company's annual report.
Medistep Healthcare Merger & Restructuring
Medistep Healthcare is incorporating a wholly owned subsidiary, Genicus Healthcare Private Limited. The new entity will manufacture nutraceuticals and allopathic products in India.
Medistep Healthcare H2 FY26 Results: Net Profit ₹3 Cr, Up 20.0% YoY
Medistep Healthcare Ltd reported revenue from operations of ₹35.8 Cr (+26.1% YoY) and net profit of ₹3 Cr (+20.0% YoY) for H2 FY26.
- Key figure
- Net profit ₹3 Cr · +20.0% YoY
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.